Publication: The Story of RU-486 in the United States
Open/View Files
Date
2001
Authors
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
The Story of RU-486 in the United States (2001 Third Year Paper)
Research Data
Abstract
In this paper, I will navigate you through the fascinating odyssey of RU-486 from its initial development in France to its official entry into the U.S. pharmaceutical market to the post-approval strife in which it is now embroiled. While many assumed that the FDA’s approval of RU-486 on September 28, 2000 would mark the final chapter in the story of the drug’s acceptance as an early pregnancy termination procedure, it actually marked the beginning of a new chapter, which ignited congressional efforts to stymie, or even abort, the growth of this chemical alternative to surgical abortion in the United States. As a result of these congressional efforts, the last chapter in the story of RU-486 remains to be written.
Description
Other Available Sources
Keywords
Food and Drug Law, RU-486, abortion pill, FDA
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service